FindTrial
Sign In

Effect of Citicoline supplimentation in the treatment of Avascular Necrosis Femoral head.

Comparative study on the effect of citicoline supplimentation in the treatment of AVN of femoral head (avascular nccrosis) of lernoral head - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051003
Enrollment
30
Registered
2023-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: Oral administration of citicoline: Citicoline 1000mg will be given orally to one group of patients receiving non surgical treatment of avascular necrosis of femoral head for a period of

Sponsors

Pushpagiri Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Precollapse stage 2. Symptomatic patients 3.Those willing to participate

Exclusion criteria

Exclusion criteria: 1.Smokers and Alcoholics not willing to stop the habits 2.Patients not tolerating citicoline and calcium 3.Patients on steroids and immunosuppresors 4.Diabetics, Renal and Hepatic failure 5.Immunodeficient patients 6. Any evidence of collapse of femoral head

Design outcomes

Primary

MeasureTime frame
clinical and radiological improvementTimepoint: Three monthly intervals upto one year—

Secondary

MeasureTime frame
Disappearance of clinical and radiological findings of avascular necrosisTimepoint: 3,6,9,12 months—

Countries

India

Contacts

Public ContactDrJohn PS

Pushpagiri Institute of Medical Sciences

drpsjohn@gmail.com9995060002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026